TR200100175T2 - Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. - Google Patents

Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.

Info

Publication number
TR200100175T2
TR200100175T2 TR2001/00175T TR200100175T TR200100175T2 TR 200100175 T2 TR200100175 T2 TR 200100175T2 TR 2001/00175 T TR2001/00175 T TR 2001/00175T TR 200100175 T TR200100175 T TR 200100175T TR 200100175 T2 TR200100175 T2 TR 200100175T2
Authority
TR
Turkey
Prior art keywords
autoimmune diseases
immunotherapy
new peptides
peptides
treatment
Prior art date
Application number
TR2001/00175T
Other languages
English (en)
Inventor
Franciscus Maria Verheijden Gijbertus
Maria Helena Boots Anna
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200100175T2 publication Critical patent/TR200100175T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bulus, otoimmün hastaliklarin önlenmesi için peptitle meydana getirilen bir tolerans tedavisinde yeni peptitlerin kullanimina ve özel olarak bunlarin, eklem kikirdaginin kronik yikiminin tedavisinde kullanilmasina iliskindir. Bulus ayrica bahsedilen peptitleri içeren farmasötik bilesimleri ve bir test numunesinde otoreaktif T hücrelerinin saptanmasi için bir test yöntemini de kapsar.
TR2001/00175T 1998-07-23 1999-07-16 Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. TR200100175T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202470 1998-07-23

Publications (1)

Publication Number Publication Date
TR200100175T2 true TR200100175T2 (tr) 2001-09-21

Family

ID=8233961

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00175T TR200100175T2 (tr) 1998-07-23 1999-07-16 Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.

Country Status (21)

Country Link
US (1) US6964766B1 (tr)
EP (1) EP1100823A2 (tr)
JP (1) JP2002521388A (tr)
KR (1) KR20010071020A (tr)
CN (1) CN1310724A (tr)
AU (1) AU758310B2 (tr)
BR (1) BR9912378A (tr)
CA (1) CA2334947A1 (tr)
CO (1) CO5090903A1 (tr)
CZ (1) CZ2001286A3 (tr)
HU (1) HUP0103384A3 (tr)
ID (1) ID27998A (tr)
IL (1) IL140825A0 (tr)
NO (1) NO20010355L (tr)
NZ (1) NZ509417A (tr)
PE (1) PE20000931A1 (tr)
PL (1) PL345958A1 (tr)
RU (1) RU2233290C2 (tr)
SK (1) SK1042001A3 (tr)
TR (1) TR200100175T2 (tr)
WO (1) WO2000005254A2 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
CA2454342A1 (en) 2001-07-24 2003-02-06 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
RU2374841C1 (ru) * 2008-04-22 2009-12-10 Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт птицеводства Способ индукции иммунологической толерантности у птиц
RU2408603C1 (ru) * 2009-07-21 2011-01-10 Ибмед Холдингс Лимитед Олигопептид, обладающий активностью морфогенетического белка хрящевого происхождения (cdmp-1) по отношению к пролиферации хондроцитов
RU2667423C1 (ru) * 2017-06-28 2018-09-19 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ПраймБиоМед" Мышиная гибридома ykl-39, клон 1b2 g4 - продуцент моноклонального антитела, обладающего специфичностью к цитоплазматическому антигену ykl-39 человека

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9023116D0 (en) * 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
WO1993015750A1 (en) * 1992-02-10 1993-08-19 Haynes Barton F Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
CA2144044A1 (en) * 1992-09-14 1994-03-31 The Brigham And Women's Hospital Reagents and methods for treating rheumatoid arthritis
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
TW575583B (en) 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
EP0805206A3 (en) 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
WO1998006859A1 (en) 1996-08-09 1998-02-19 Human Genome Sciences, Inc. Human chitinase alpha and chitinase alpha-2

Also Published As

Publication number Publication date
AU758310B2 (en) 2003-03-20
RU2233290C2 (ru) 2004-07-27
KR20010071020A (ko) 2001-07-28
CA2334947A1 (en) 2000-02-03
NZ509417A (en) 2003-03-28
WO2000005254A2 (en) 2000-02-03
WO2000005254A3 (en) 2000-06-15
AU5411299A (en) 2000-02-14
EP1100823A2 (en) 2001-05-23
RU2001105086A (ru) 2004-01-20
BR9912378A (pt) 2001-04-17
JP2002521388A (ja) 2002-07-16
NO20010355D0 (no) 2001-01-22
PE20000931A1 (es) 2000-09-16
CO5090903A1 (es) 2001-10-30
IL140825A0 (en) 2002-02-10
ID27998A (id) 2001-05-03
PL345958A1 (en) 2002-01-14
HUP0103384A2 (hu) 2001-12-28
CN1310724A (zh) 2001-08-29
US6964766B1 (en) 2005-11-15
NO20010355L (no) 2001-03-20
SK1042001A3 (en) 2001-09-11
CZ2001286A3 (en) 2001-08-15
HUP0103384A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
BR0011132A (pt) Método e "kit" para amostragem e armazenagem de amostras biológicas
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DE60032486D1 (de) Prion protein peptide und deren verwendung
TR199802082T2 (tr) Otoantigen ve otoimün hastaliklarin imünoterapisinde kullanilmak için otoantigen yapisal olarak iliskili proteinler.
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
TR199901569T2 (tr) Tüberkülozun teshisi için bilesikler ve yöntemler.
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
BR9506377A (pt) Peptídeo compreendendo uma subsequéncia de gp-39 hc proteina gp-39 hc ou peptideos composição farmacéutica uso da proteina gp-39 hc ou um ou mais dos peptídeos composição de diagnostico e processo de diagnóstico e kit de teste para a detecção de céçiças t auto-reativas ativadas
ES2173471T3 (es) Analisis para homocisteina y homocisteina desulfurasa a partir de tricomonas viginalis de protozoos.
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
EA199900138A1 (ru) Обнаружение активности гепараназы млекопитающих и очистка гепараназы млекопитающих
DK0833842T3 (da) Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme
DE69935414D1 (en) Humanes btrcp protein
EA200001127A1 (ru) Бактериальные феромоны и их использование
WO2000005254A3 (en) Novel peptides for use in immunotherapy of autoimmune diseases
ATE390440T1 (de) Neuroaktive peptide
DK0972032T3 (da) Peptider til behandling af systemisk lupus erythematosus
SE0003099D0 (sv) Adhesive protein and uses therefore
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
UA33641A (uk) Спосіб визначення тривалості цементних зразків при циклічному стиску
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.